Astrazeneca Notizie - AZN

Buy
Sell
Le migliori offerte per accedere ai dati in tempo reale
Borsa di Londra
Sottoscrizione Mensile
per soli
22,17 €
Book Borsa di Londra
Sottoscrizione Mensile
per soli
59,13 €
World Guru
Sottoscrizione Mensile
per soli
126,50 €
Prezzi IVA esclusa
Nome Azione Simbolo Borsa Mercato Tipo ISIN Descrizione
Astrazeneca Plc AZN Londra Azione Ordinaria GB0009895292 ORD SHS $0.25
  Variazione Variazione % Quotazione Attuale Max Min Apertura Chiusura Ora
  3,00 0,04% 7.170,00 7.277,00 7.167,00 7.263,00 7.167,00 17:29:56
quotazione »
Settore Industriale
PHARMACEUTICALS & BIOTECHNOLOGY

Ultime notizie

Data Ora Fonte Titolo
23/9/201909:28ALNCAstraZeneca Gets European Approval For Diabetes Treatment..
23/9/201908:01UKREGAstraZeneca PLC Qtrilmet recommended for approval in EU by..
19/9/201919:01DJNLONDON MARKETS: U.K. Stocks Snap Three-day Losing Run
18/9/201909:13ALNCAstraZeneca Could Pay Ironwood USD125 Million In Altered..
18/9/201908:46DJNAstraZeneca Amends China Collaboration Agreement With..
18/9/201908:01UKREGAstraZeneca PLC AstraZeneca amends collaboration with..
16/9/201914:24DJNAstraZeneca: FDA Grants Fast Track Designation for Farxiga..
16/9/201910:12ALNCAstraZeneca's Farixga Gets US Fast Track Designation In..
11/9/201910:35ALNCIN THE KNOW: Citigroup Remains Upbeat On AstraZeneca's..
09/9/201910:27DJNAstraZeneca: Imfinzi Shows Efficacy in Treating Small-Cell..
09/9/201910:10ALNCAstraZeneca's Imfinzi Improves Lung Cancer Survival In..
09/9/201909:38UKREGAstraZeneca PLC Imfinzi is first immunotherapy to show both
07/9/201902:26DJNADC Therapeutics Files for IPO
04/9/201909:07ALNCAstraZeneca Lung Cancer Drug Approved As First-Line..
04/9/201908:55DJNAstraZeneca: Tagrisso Approved in China as 1st-Line..
04/9/201908:11UKREGAstraZeneca PLC Tagrisso approved in China as a 1st-line..
02/9/201916:00UKREGAstraZeneca PLC Total Voting Rights
02/9/201913:45DJNLONDON MARKETS: Pound Tumbles As British Factory Output Hits..
02/9/201913:20ALNCIN THE KNOW: AstraZeneca Farxiga Study Could Drive Consensus..
02/9/201912:04DJNEUROPE MARKETS: European Stocks Nudge Higher Despite Fresh..
02/9/201909:48ALNCTOP NEWS: Astra Reports Positive Study Results For Brilinta,..
02/9/201908:05UKREGAstraZeneca PLC Brilinta reduced the risk of cardiovascular..
02/9/201908:00UKREGAstraZeneca PLC Detailed results from Phase III DAPA-HF..
29/8/201915:30ALNCIN THE KNOW: Shore "Positively Surprised" By AstraZeneca..
29/8/201909:06ALNCAstraZeneca Drug Anifrolumab Meets Primary Endpoint In Tulip..
29/8/201908:42DJNAstraZeneca: Anifrolumab Effective in Phase 3 Study
29/8/201908:00UKREGAstraZeneca PLC Anifrolumab Phase III trial meets primary..
28/8/201914:23DJNAstraZeneca COPD Drug Meets Primary Endpoints in Phase 3..
28/8/201909:38ALNCAstraZeneca Gets Breztri Aerosphere Trial Success, Fasenra..
28/8/201908:54DJNAstraZeneca: Fasenra Granted Orphan Drug Status by FDA
28/8/201908:41DJNAstraZeneca: Breztri Aerosphere Phase 3 Trial Successful
28/8/201908:05UKREGAstraZeneca PLC Fasenra granted US Orphan Drug Designation..
28/8/201908:00UKREGAstraZeneca PLC Breztri Aerosphere Phase III ETHOS trial met
27/8/201914:16DJNAstraZeneca Drug in Kidney Disease Study Gets Fast Track..
27/8/201909:50ALNCAstraZeneca's Farixga Gets US Fast Track Designation In..
22/8/201909:36ALNCChina Approves Expanded Release Of AstraZeneca Anaemia Drug
22/8/201909:14DJNAstraZeneca China Partner Granted Marketing Authorization..
22/8/201908:58DJNAstraZeneca to Buy US FDA Priority Review Voucher for $95..
22/8/201908:01UKREGAstraZeneca PLC Roxadustat approved in China for the..
21/8/201908:46ALNCTOP NEWS: AstraZeneca Drug Fails To Improve Survival In..
21/8/201908:41DJNAstraZeneca: Imfinzi, Tremelimumab Combination Didn't Meet..
21/8/201908:00UKREGAstraZeneca PLC Update on the Phase III NEPTUNE trial
20/8/201908:46ALNCAstra's Farxiga Meets Primary Endpoint For Heart Failure..
20/8/201908:40DJNAstraZeneca: Farxiga Met Primary Endpoint in Landmark Phase..
20/8/201908:01UKREGAstraZeneca PLC Farxiga met primary endpoint in landmark..
19/8/201909:16ALNCAstraZeneca Appoints Vodafone Non-Executive Michel Demare To..
19/8/201908:00UKREGAstraZeneca PLC Directorate Change
16/8/201915:26DJNCorrection to AstraZeneca's Lynparza Clinical Trial Article..
14/8/201909:42ALNCTOP NEWS: AstraZeneca Leukaemia Drug Gets US Regulatory..
14/8/201909:00DJNAstraZeneca's Lynparza Successful in Second Ovarian Cancer..
Accedi alle altre notizie sul titolo »
La tua Cronologia
LSE
AZN
Astrazenec..
Registrati ora per visualizzare questi strumenti nella tua watchlist streaming.

Il Monitor ADVFN ti permette di visualizzare fino a 110 titoli ed è completamente gratuito.

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

P: V: D:20190923 20:38:34